MLH1 and endometrial cancer: Regarding the clinical characteristics, a slightly early mean age at CRC and endometrial cancer diagnoses was observed in the families without the MLH1 Ile219Val polymorphism in comparison to the families harboring the MLH1 polymorphism (45 and 44 years vs. 49 and 46 years, respectively) (p > 0.05).